Kawasaki syndrome

Also found in: Dictionary, Thesaurus, Encyclopedia.

Kawasaki Syndrome



Kawasaki syndrome is a potentially fatal inflammatory disease that affects several organ systems in the body, including the heart, circulatory system, mucous membranes, skin, and immune system. It occurs primarily in infants and children but has also been identified in adults as old as 34 years. Its cause is unknown.


Kawasaki syndrome, also called mucocutaneous lymph node syndrome (MLNS), is an inflammatory disorder with potentially fatal complications affecting the heart and its larger arteries. Nearly twice as many males are affected as females. Although persons of Asian descent are affected more frequently than either black or white individuals, there does not appear to be a distinctive geographic pattern of occurrence. Eighty percent of cases involve children under the age of four. Although the disease usually appears in individuals, it sometimes affects several members of the same family and occasionally occurs in small epidemics.

Causes and symptoms

The specific cause of Kawasaki syndrome is unknown, although the disease resembles infectious illnesses in many ways. It has been suggested that Kawasaki syndrome represents an allergic reaction or other unusual response to certain types of infections. Some researchers think that the syndrome may be caused by the interaction of an immune cell, called the T cell, with certain poisons (toxins) secreted by bacteria.
Kawasaki syndrome has an abrupt onset, with fever as high as 104°F (40°C) and a rash that spreads over the patient's chest and genital area. The fever is followed by a characteristic peeling of the skin beginning at the fingertips and toenails. In addition to the body rash, the patient's lips become very red, with the tongue developing a "strawberry" appearance. The palms, soles, and mucous membranes that line the eyelids and cover the exposed portion of the eyeball (conjuntivae) become purplish-red and swollen. The lymph nodes in the patient's neck may also become swollen. These symptoms may last from two weeks to three months, with relapses in some patients.
In addition to the major symptoms, about 30% of patients develop joint pains or arthritis, usually in the large joints of the body. Others develop pneumonia, diarrhea, dry or cracked lips, jaundice, or an inflammation of the membranes covering the brain and spinal cord (meningitis). A few patients develop symptoms of inflammation in the liver (hepatitis), gallbladder, lungs, or tonsils.
About 20% of patients with Kawasaki syndrome develop complications of the cardiovascular system. These complications include inflammation of the heart tissue (myocarditis), disturbances in heartbeat rhythm (arrhythmias), and areas of blood vessel dilation (aneurysms) in the coronary arteries. Other patients may develop inflammation of an artery (arteritis) in their arms or legs. Complications of the heart or arteries begin to develop around the tenth day after the illness begins, when the fever and rash begin to subside. A few patients may develop gangrene, or the death of soft tissue, in their hands and feet. The specific causes of these complications are not yet known.


Because Kawasaki syndrome is primarily a disease of infants and young children, the disease is most likely to be diagnosed by a pediatrician. The physician will first consider the possible involvement of other diseases that cause fever and skin rashes, including scarlet fever, measles, Rocky Mountain spotted fever, toxoplasmosis (a disease carried by cats), juvenile rheumatoid arthritis, and a blistering and inflammation of the skin caused by reactions to certain medications (Stevens-Johnson syndrome).
Once other diseases have been ruled out, the patient's symptoms will be compared with a set of diagnostic criteria. The patient must have a fever lasting five days or longer that does not respond to antibiotics, together with four of the following five symptoms:
  • Inflammation of the conjunctivae of both eyes with no discharge
  • At least one of the following changes in the mucous membranes of the mouth and throat: "strawberry" tongue; cracked lips; or swollen throat tissues
  • At least one of the following changes in the hands or feet: swelling caused by excess fluid in the tissues; peeling of the skin; or abnormal redness of the skin
  • A skin eruption or rash associated with fever (exanthem) on the patient's trunk
  • Swelling of the lymph nodes in the neck to a size greater than 1.5 cm.
Since the cause of Kawasaki syndrome is unknown, there are no laboratory tests that can confirm the diagnosis. The following test results, however, are associated with the disease:
  • Blood tests show a high white blood cell count, high platelet count, a high level of protein in the blood serum, and mild anemia
  • Chest x ray may show enlargement of the heart (cardiomegaly)
  • Urine may show the presence of pus or an abnormally high level of protein
  • An electrocardiogram may show changes in the heartbeat rhythm
In addition to these tests, it is important to take a series of echocardiograms during the course of the illness because 20% of Kawasaki patients will develop coronary aneurysms or arteritis that will not appear during the first examination.


Kawasaki syndrome is usually treated with a combination of aspirin, to control the patient's fever and skin inflammation, and high doses of intravenous immune globulin to reduce the possibility of coronary artery complications. Some patients with heart complications may be treated with drugs that reduce blood clotting or may receive corrective surgery.
Follow-up care includes two to three months of monitoring with chest x rays, electrocardiography, and echocardiography. Treatment with aspirin is often continued for several months.


Most patients with Kawasaki syndrome will recover completely, but about 1-2% will die as a result of blood clots forming in the coronary arteries or as a result of a heart attack. Deaths are sudden and unpredictable. Almost 95% of fatalities occur within six months of infection, but some have been reported as long as 10 years afterward. Long-term follow-up of patients with aneurysms indicates that about half show some healing of the aneurysm. The remaining half has a high risk of heart complications in later life.



Shandera, Wayne X., and Maria E. Carlini. "Infectious Diseases: Viral & Rickettsial." In Current Medical Diagnosis and Treatment, 1998, edited by Stephen McPhee, et al., 37th ed. Stamford: Appleton & Lange, 1997.

Key terms

Aneurysm — Dilation of an artery caused by thinning and weakening of the vessel wall.
Arrythmia — Abnormal heart rhythm.
Arteritis — Inflammation of an artery.
Cardiomegaly — An enlarged heart.
Conjunctivae — The mucous membranes that cover the exposed area of the eyeball and line the inner surface of the eyelids.
Exanthem — A skin eruption associated with a disease, usually one accompanied by fever as in Kawasaki syndrome.
Gangrene — The death of soft tissue in a part of the body, usually caused by obstructed circulation.
Hepatitis — Inflammation of the liver.
Meningitis — Inflammation of the membranes, called the meninges, covering the brain and spinal cord.
Mucocutaneous lymph node syndrome (MLNS) — Mucocutaneous lymph node syndrome, another name for Kawasaki syndrome. The name comes from the key symptoms of the disease, which involve the mucous membranes of the mouth and throat, the skin, and the lymph nodes.
Myocarditis — Inflammation of the heart muscle.
Stevens-Johnson syndrome — A severe inflammatory skin eruption that occurs as a result of an allergic reaction or respiratory infection.
T cell — A type of white blood cell that develops in the thymus gland and helps to regulate the immune system's response to infections or malignancy.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.

mu·co·cu·ta·ne·ous lymph node syn·drome

a systemic vasculitis of unknown origin that occurs primarily in children under 8 years of age. Symptoms include a fever lasting more than 5 days; polymorphic rash; erythematous, dry, cracking lips; conjunctival injection; swelling of the hands and feet; irritability; adenopathy; and a perineal desquamative rash. Approximately 20% of untreated patients may develop coronary artery aneurysms. As the child recovers from the illness, thrombocytosis and peeling of the fingertips occur.
Farlex Partner Medical Dictionary © Farlex 2012

Kawasaki syndrome

An acute idioapathic febrile illness that primarily affects children under age 5, especially males, and has a winter-spring seasonality.

Clinical findings
Fever; cervical lymphadenopathy; palmoplantar and mucosal erythaema and oedema; conjunctivitis; gingivitis; maculoerythematous glove-and-sock rash over the hands and feet, which becomes hard, oedematous and sloughs; aneurysms of small- and medium-sized coronary, occasionally peripheral, arteries, with arteritis. Other findings include conjunctival oedema, upper respiratory tract oedema, pharyngeal injection and truncal lymphadenopathy.
Uncertain; various bacteria have been implicated, though none definitively.
Increased ESR, CRP, complement, immunoglobulins.
Gammaglobulin in IV bolus, aspirin IV.
May cause sudden death; 1–5% die of disease.

Kawasaki syndrome case definition (CDC)
Fever of 5 days’ duration (or fever post-IV immunoglobulin if given before 5th day of fever), and 4 of following 5 signs:
• Rash;     
• Cervical lymphadenopathy (1.5+ cm in diameter);
• Bilateral conjunctival injection;   
• Oral mucosal changes—erythaema, fissuring and xerostomia, “strawberry tongue”;    
• Peripheral extremity changes—e.g., acral erythema or oedema, periungual and/or generalised desquamation, polymorphous exanthematous rash.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

Ka·wa·sa·ki dis·ease

, Kawasaki syndrome (kă-wă-sah'kē di-zēz', sin'drōm)
A systemic vasculitis of unknown origin that occurs primarily in children younger than 8 years of age. Symptoms include a fever lasting more than 5 days; polymorphic rash; erythematous, dry, cracking lips; conjunctival injection; swelling of the hands and feet; irritability; adenopathy; and a perineal desquamative rash. Approximately 20% of untreated patients may develop coronary artery aneurysms. Treatment includes oral aspirin at high dosage, immune globulin administered intravenously, and supportive care. As the child recovers from the illness, thrombocytosis and peeling of the fingertips occur.
Synonym(s): mucocutaneous lymph node syndrome.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012


Tomisaku, 20th century Japanese pediatrician.
Kawasaki disease - a polymorphous erythematous febrile, sometimes epidemic, disease of unknown etiology occurring in children. Synonym(s): Kawasaki syndrome; mucocutaneous lymph node syndrome
Kawasaki syndrome - Synonym(s): Kawasaki disease
Medical Eponyms © Farlex 2012
Kawasaki disease
mucocutaneous lymph node syndrome,
, Kawasaki syndrome (kah-wă-sah'kē di-zēz', sin'drōm)
Medical Dictionary for the Dental Professions © Farlex 2012
References in periodicals archive ?
There's no cure as yet for Kawasaki syndrome but medication, if given by a paediatrician within the first 10 days of fever, may help prevent possible heart complications.
The Travolta's insistence that he had Kawasaki Syndrome has meant that these treatments have not been an option.
Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
"This usually occurs on the first day in Kawasaki syndrome," Dr.
Humidifier use appears to be a risk factor for Kawasaki syndrome, said Tracee A.
In the case of Kawasaki Syndrome (KS), it is not as uncommon as one might think.
The Food and Drug Administration (FDA) first licensed IGIV in 1981 and has approved its use for six conditions: primary immunodeficiencies, immune-mediated thrombocytopenia, Kawasaki syndrome, recent bone marrow transplantation in patients aged [greater than or equal to]20 years, chronic B-cell lymphocytic leukemia, and pediatric human immunodeficiency virus type 1 (HIV-1) infection (Table 1).
Yet many commercial carpet-cleaning solutions and powders have been linked to outbreaks of Kawasaki Syndrome, an inflammation of blood vessels that is the leading cause of acquired heart disease in infants and youngsters.